Home › Trial NCT06511674
Vulnerability and Risk of Neuropathic Pain in Cancer
- Trial IDNCT06511674
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity Hospital, Clermont-Ferrand
- Enrollment625
- Start date2024-10-28
- ConditionsNeuropathic Pain · Cancer · Predictive
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.